BridgeBio Pharma Inc. (BBIO)
undefined
undefined%
At close: undefined
27.49
-0.04%
After-hours Dec 13, 2024, 04:15 PM EST

Income Statement (Annual)

Get detailed income statement breakdowns, uncovering revenue, expenses, and much more.
Year FY23 FY22 FY21 FY20 FY19 FY18 FY17
Revenue 9.30M 77.65M 69.72M 8.25M 40.56M - -
Cost of Revenue 2.45M 3.43M 3.11M 3.09M 2.50M - 260.00K
Gross Profit 6.86M 74.21M 66.60M 5.16M 38.06M - -260.00K
Operating Income -607.37M -471.87M -579.75M -474.48M -266.24M -183.66M -43.86M
Interest Income 18.04M 7.54M 1.13M 4.01M 8.91M 2.00M 39.00K
Pretax Income -653.25M -484.65M -586.45M -505.49M -288.58M -169.45M -43.83M
Net Income -643.20M -493.96M -639.30M -483.93M -260.44M -130.75M -30.57M
Selling & General & Admin 150.59M 143.19M 192.21M 145.68M 94.35M 43.59M 13.30M
Research & Development 455.71M 402.90M 454.14M 337.05M 209.95M 140.07M 30.56M
Other Expenses 7.93M 100.45M 35.82M 1.63M -1.21M -1.29M -
Operating Expenses 614.23M 546.09M 646.35M 482.73M 304.30M 183.66M 43.86M
Interest Expense 81.29M 80.44M 46.78M 36.66M 8.77M 2.55M 13.00K
Selling & Marketing Expenses - - - - - - -
Cost & Expenses 616.67M 546.09M 646.35M 482.73M 306.80M 183.66M 43.86M
Income Tax - 9.31M 52.84M -21.56M -28.15M 16.76M -13.49M
Shares Outstanding (Basic) 162.79M 147.47M 144.36M 118.00M 105.10M 92.33M 92.33M
Shares Outstanding (Diluted) 162.79M 147.47M 144.36M 118.00M 105.10M 92.33M 92.33M
EPS (Basic) -3.95 -3.35 -4.43 -4.1 -2.48 -1.42 -0.33
EPS (Diluted) -3.95 -3.35 -4.43 -4.1 -2.48 -1.42 -0.33
EBITDA -565.47M -397.44M -533.83M -465.75M -279.82M -183.41M -43.56M
Depreciation & Amortization 6.49M 6.77M 5.84M 3.09M 859.00K 245.00K 260.00K